Inflammatory bowel disease (IBD) often lacks a definitive diagnostic standard, leading to diagnoses through exclusion. This study aimed to create a predictive model for IBD using bioinformatics and deep learning while identifying potential biomarkers to improve management outcomes. Analyses indicated that differentially expressed genes in IBD patients were associated with cytokine activity and pro-inflammatory pathways. A significant correlation was found between M1 macrophage infiltration and IBD pathogenesis. Through a Weighted Gene Correlation Network Analysis, we identified 31 genes related to M1 macrophages and 18 metatranscriptomic features linked to IBD. Integrating these, we developed a two-class predictive model, demonstrating the effectiveness of deep learning techniques, particularly neural networks in IBD diagnostics. Using the SHAP algorithm, we highlighted 10 critical features, primarily host genetic variants, that illustrate the interaction between gut microbiota and host genetics in IBD. Furthermore, our findings emphasize the pivotal role of M1 macrophage-associated CXCL10 in IBD, suggesting its potential as a promising biomarker and therapeutic target in managing IBD. We envision a future where global analyses of IBD data can be enhanced through artificial intelligence, yielding more profound insights into the etiological factors driving IBD pathology.
Keywords: Artificial intelligence; CXCL10; Inflammatory bowel disease; Interpretable prediction model; M1 macrophage.
Copyright © 2025 Elsevier B.V. All rights reserved.